This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Biotech Stocks Poised for Breakouts

Stocks in this article: VPHM SGMO TSPT GERN DYAX


Another stock that's setting up to trigger a near-term breakout trade is Geron (GERN), a biopharmaceutical company developing therapies for cancer. This stock is off to a decent start so far in 2012, with shares up over 17%.

If you look at the chart for GERN, you'll see that this stock has been trading within range for the past month, with shares moving between $1.50 and $1.79 a share. That move has also started to coil up the stock between its 50-day moving average at $1.52 and its 200-day moving average of $1.73 a share. Traders should now look to play a move in GERN above its 200-day at $1.73 and above the upper end of that range. A high-volume move above those levels could spark a huge move higher in this stock.

Traders should now look for long-biased traders in GERN if this stock can manage to clear its 200-day at $1.73 a share, and then take out some more overhead resistance at $1.79 to $1.89 a share with high volume. Look for a sustained move or close above those levels with volume that's near or above 688,470 shares. If we get that action soon, then GERN could easily re-test and possibly take out its next major overhead resistance levels at $2.22 to $2.60 a share.

One could be a buyer of GERN off any weakness, and simply use a stop around $1.60 or even just below $1.50 a share. You could also just buy off strength once GERN once GERN starts to challenge those breakout levels, and then simply use a stop that sits a few percentage points below its 200-day moving average.

5 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs